These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 25789687)
1. Finasteride reduces microvessel density and expression of vascular endothelial growth factor in renal tissue of diabetic rats. Tian HL; Zhao CX; Wu HY; Xu ZX; Wei LS; Zhao RT; Jin DL Am J Med Sci; 2015 Jun; 349(6):516-20. PubMed ID: 25789687 [TBL] [Abstract][Full Text] [Related]
2. [Expression of VEGF in kidney of diabetic rats]. Chen ZJ; Yang YB; Huang SM Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jul; 38(4):633-6. PubMed ID: 17718428 [TBL] [Abstract][Full Text] [Related]
3. Effect of pioglitazone on expression of hypoxia-inducible factor 1α and vascular endothelial growth factor in ischemic hindlimb of diabetic rats. Zhang M; Gao X; Bai SJ; Ye XM; Zhang J Eur Rev Med Pharmacol Sci; 2014; 18(9):1307-14. PubMed ID: 24867508 [TBL] [Abstract][Full Text] [Related]
4. The effect of finasteride on the expression of vascular endothelial growth factor and microvessel density: a possible mechanism for decreased prostatic bleeding in treated patients. Pareek G; Shevchuk M; Armenakas NA; Vasovic L; Hochberg DA; Basillote JB; Fracchia JA J Urol; 2003 Jan; 169(1):20-3. PubMed ID: 12478093 [TBL] [Abstract][Full Text] [Related]
5. [Effect of Cordyceps sinensis on expressions of HIF-1α and VEGF in the kidney of rats with diabetic nephropathy]. Yuan M; Tang R; Zhou Q; Liu K; Xiao Z; Pouranan V Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2013 May; 38(5):448-57. PubMed ID: 23719521 [TBL] [Abstract][Full Text] [Related]
6. Effects on protein kinase C-beta inhibition on glomerular vascular endothelial growth factor expression and endothelial cells in advanced experimental diabetic nephropathy. Kelly DJ; Buck D; Cox AJ; Zhang Y; Gilbert RE Am J Physiol Renal Physiol; 2007 Aug; 293(2):F565-74. PubMed ID: 17522264 [TBL] [Abstract][Full Text] [Related]
7. Imbalance of glomerular VEGF-NO axis in diabetic rats: prevention by chronic therapy with propyl gallate. Tian S; Gan Y; Li J; Wang L; Shen J; Liu T; Ye T; Liu H; Liu D; Deng Y; Wang W J Nephrol; 2011; 24(4):499-506. PubMed ID: 21425119 [TBL] [Abstract][Full Text] [Related]
8. Finasteride effects on hypoxia and angiogenetic markers in benign prostatic hyperplasia. Lekas AG; Lazaris AC; Chrisofos M; Papatsoris AG; Lappas D; Patsouris E; Deliveliotis C Urology; 2006 Aug; 68(2):436-41. PubMed ID: 16904480 [TBL] [Abstract][Full Text] [Related]
9. Protective effects of adiponectin on uncoupling of glomerular VEGF-NO axis in early streptozotocin-induced type 2 diabetic rats. Hou N; Huang N; Han F; Zhao J; Liu X; Sun X Int Urol Nephrol; 2014 Oct; 46(10):2045-51. PubMed ID: 25118612 [TBL] [Abstract][Full Text] [Related]
10. Inhibition of vascular endothelial growth factor (VEGF) does not affect early renal changes in a rat model of lean type 2 diabetes. Schrijvers BF; De Vriese AS; Tilton RG; Van de Voorde J; Denner L; Lameire NH; Flyvbjerg A Horm Metab Res; 2005 Jan; 37(1):21-5. PubMed ID: 15702434 [TBL] [Abstract][Full Text] [Related]
12. Possible role of VEGF in the progression of kidney disease in streptozotocin (STZ)-induced diabetic rats: effects of an ACE inhibitor and an angiotensin II receptor antagonist. Kakizawa H; Itoh Y; Imamura S; Matsumoto T; Ishiwata Y; Ono Y; Yamamoto K; Kato T; Hayakawa N; Oda N; Goto Y; Goto Y; Nagasaka A; Senda T; Itoh M Horm Metab Res; 2004 Jul; 36(7):458-64. PubMed ID: 15305228 [TBL] [Abstract][Full Text] [Related]
13. Effects of finasteride on the vascular surface density, number of microvessels and vascular endothelial growth factor expression of the rat prostate. Canda AE; Mungan MU; Yilmaz O; Yorukoglu K; Tuzel E; Kirkali Z Int Urol Nephrol; 2006; 38(2):275-80. PubMed ID: 16868697 [TBL] [Abstract][Full Text] [Related]
14. [Effects of valsartan on the renal vascular endothelial growth factor and its receptor flk-1 of diabetic rats]. Tang WX; Chen ZJ; Huang SM; Tao Y; Fu P Sichuan Da Xue Xue Bao Yi Xue Ban; 2008 Mar; 39(2):223-6, 230. PubMed ID: 18630688 [TBL] [Abstract][Full Text] [Related]
15. [The effects of VEGF-R inhibitor on podocytopathy of rats with type I diabetic nephropathy]. Wang S; Li Y; Huang YJ Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Sep; 27(9):1003-6. PubMed ID: 21906476 [TBL] [Abstract][Full Text] [Related]
16. Quantitave and qualitative changes in vascular endothelial growth factor gene expression in glomeruli of patients with type 2 diabetes. Bortoloso E; Del Prete D; Dalla Vestra M; Gambaro G; Saller A; Antonucci F; Baggio B; Anglani F; Fioretto P Eur J Endocrinol; 2004 Jun; 150(6):799-807. PubMed ID: 15191350 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin II receptor blocker attenuates overexpression of vascular endothelial growth factor in diabetic podocytes. Lee EY; Shim MS; Kim MJ; Hong SY; Shin YG; Chung CH Exp Mol Med; 2004 Feb; 36(1):65-70. PubMed ID: 15031673 [TBL] [Abstract][Full Text] [Related]
18. Peroxynitrite plays a key role in glomerular lesions in diabetic rats. Xiao H; Li Y; Qi J; Wang H; Liu K J Nephrol; 2009; 22(6):800-8. PubMed ID: 19967660 [TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor is increased during early stage of diabetic nephropathy in type II diabetic rats. Cha DR; Kang YS; Han SY; Jee YH; Han KH; Han JY; Kim YS; Kim NH J Endocrinol; 2004 Oct; 183(1):183-94. PubMed ID: 15525586 [TBL] [Abstract][Full Text] [Related]
20. [The expression and significance of the angiopoietin-1 in the kidney of diabetic rats]. Yang YB; Chen ZJ; Liu F; Huang SM Sichuan Da Xue Xue Bao Yi Xue Ban; 2007 Jan; 38(1):93-6, 104. PubMed ID: 17294737 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]